Patent details

EP2332977 Title: ActRII receptor polypeptides

Basic Information

Publication number:
EP2332977
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP100092584
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ActRII receptor polypeptides
French Title of Invention:
Polypeptides du récepteur AvtRII
German Title of Invention:
AvtRII-Rezeptor-Polypeptide
SPC Number:

Dates

Filing date:
25/07/2005
Grant date:
25/11/2015
EP Publication Date:
25/11/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/06/2011
EP B1 Publication Date:
25/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/07/2005
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/02/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Knopf John
Address:
United States (US)

2

Name:
Seehra Jasbir
Address:
United States (US)

Priority

Priority Number:
590765 P
Priority Date:
23/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/705;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/06/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages